Home › Mycosis Fungoides › New York
Mycosis Fungoides clinical trials in New York
7 studies for Mycosis Fungoides are looking for participants at sites in New York.
Cities in New York
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- Columbia University, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT04234048A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
- Rochester Skin Lymphoma Medical Group. PLLC, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06854653A Registry for People With T-cell Lymphoma
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities), Commack
- Memorial Sloan Kettering Westchester (All protocol activities), Harrison
- Weill Cornell Medical Center (Data Collection Only), New York
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Photopheresis in Early-stage Mycosis Fungoides
- Columbia University Irving Medical Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 27, 2026 · NCT05680558Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, East White Plains
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT03587844A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT05296304From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.